197 tracked 13F filers disclose a position in TRVI as of the latest SEC 13F filings, a combined $1.9B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | NEA Management Company, LLC | $157.7M | 13.2M | —Held | Q1 2026 | |
| 2 | BlackRock, Inc. | $122.2M | 10.2M | ▲+1.1% Added · +114K sh | Q1 2026 | |
| 3 | Frazier Life Sciences Management, L.P. | $185.4M | 9.9M | ▼~0% Reduced · −100 sh | Q2 2026 | |
| 4 | FMR LLC | $95.9M | 8.0M | ▲+24% Added · +1.5M sh | Q1 2026 | |
| 5 | Vivo Capital, LLC | $95.0M | 5.1M | —Held | Q2 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $59.4M | 5.0M | →First observed position No prior filed position | Q1 2026 | |
| 7 | MARSHALL WACE, LLP | $47.3M | 4.0M | ▼−13% Reduced · −615K sh | Q1 2026 | |
| 8 | Rubric Capital Management LP | $44.3M | 3.7M | ▼−1.4% Reduced · −54K sh | Q1 2026 | |
| 9 | MPM BioImpact LLC | $39.4M | 3.3M | ▲+0.3% Added · +11K sh | Q1 2026 | |
| 10 | VIKING GLOBAL INVESTORS LP | $38.2M | 3.2M | —Held | Q1 2026 | |
| 11 | FRONTIER CAPITAL MANAGEMENT CO LLC | $57.3M | 3.1M | ▲+54% Added · +1.1M sh | Q2 2026 | |
| 12 | STATE STREET CORP | $56.5M | 3.0M | ▲+14% Added · +362K sh | Q2 2026 | |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | $54.6M | 2.9M | ▲+5.4% Added · +150K sh | Q2 2026 | |
| 14 | ALLIANCEBERNSTEIN L.P. | $35.6M | 2.8M | ▼−7.7% Reduced · −238K sh | Q1 2026 | |
| 15 | EVENTIDE ASSET MANAGEMENT, LLC | $31.3M | 2.6M | —Held | Q1 2026 | |
| 16 | ORBIMED ADVISORS LLC | $29.3M | 2.5M | ▼−23% Reduced · −736K sh | Q1 2026 | |
| 17 | Logos Global Management LP | $28.6M | 2.4M | ▲+55% Added · +850K sh | Q1 2026 | |
| 18 | Artia Global Partners LP | $41.2M | 2.2M | ▲+9.8% Added · +197K sh | Q2 2026 | |
| 19 | Vestal Point Capital, LP | $25.8M | 2.2M | ▲New +2.2M sh | Q1 2026 | |
| 20 | ACORN CAPITAL ADVISORS, LLC | $40.0M | 2.1M | —Held | Q2 2026 | |
| 21 | Affinity Asset Advisors, LLC | $23.9M | 2.0M | ▼−7.0% Reduced · −150K sh | Q1 2026 | |
| 22 | EMERALD ADVISERS, LLC | $33.5M | 1.8M | ▼−2.3% Reduced · −42K sh | Q2 2026 | |
| 23 | Siren, L.L.C. | $33.3M | 1.8M | —Held | Q2 2026 | |
| 24 | Pictet Asset Management Holding SA | $20.4M | 1.7M | ▲+11% Added · +174K sh | Q1 2026 | |
| 25 | RAYMOND JAMES FINANCIAL INC | $20.1M | 1.7M | ▼−4.5% Reduced · −79K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 10 funds opened a new position in TRVI and 24 added to an existing one, while 20 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| AMAZON.COM INCAMZN | 92 funds | $118.0B |
| ELI LILLY & COLLY | 92 funds | $50.4B |
| NVIDIA CORPNVDA | 89 funds | $245.5B |
| MICROSOFT CORPMSFT | 88 funds | $164.5B |
| ALPHABET INC-CL AGOOGL | 88 funds | $94.3B |
| BROADCOM INCAVGO | 86 funds | $101.6B |
| MICRON TECHNOLOGY INCMU | 86 funds | $26.0B |
| REVOLUTION MEDICINES INCRVMD | 85 funds | $3.7B |
| APPLE INCAAPL | 84 funds | $181.1B |
| META PLATFORMS INC-CLASS AMETA | 84 funds | $69.7B |
| VISA INC-CLASS A SHARESV | 82 funds | $38.9B |
| JOHNSON & JOHNSONJNJ | 82 funds | $26.6B |
Ranked by how many of TRVI's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Mar 25, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | Sell (S) | 3K | $17K |
| Mar 21, 2025 | GOOD JENNIFER L | President & CEO, Director | Sell (S) | 5K | $35K |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Sell (S) | 4K | $31K |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Sell (S) | 77K | $518K |
| Sep 9, 2024 | GOOD JENNIFER L | President & CEO, Director | Sell (S) | 2K | $6K |
| Sep 6, 2024 | GOOD JENNIFER L | President & CEO, Director | Sell (S) | 4K | $13K |
| Sep 5, 2024 | GOOD JENNIFER L | President & CEO, Director | Sell (S) | 40K | $125K |
| Sep 4, 2024 | GOOD JENNIFER L | President & CEO, Director | Sell (S) | 11K | $33K |
| Sep 3, 2024 | GOOD JENNIFER L | President & CEO, Director | Sell (S) | 4K | $12K |
| Aug 27, 2024 | Meeker David P | Director | Sell (S) | 5K | $13K |
| Aug 19, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | Sell (S) | 16K | $49K |
| Aug 16, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | Sell (S) | 19K | $52K |
Connected entities for TRVI
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/TRVI/capital-change-brief"
Use Arkolith's capital_change_brief for TRVI. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for TRVI. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.